MedPath

Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance

Phase 4
Completed
Conditions
HIV
Interventions
Registration Number
NCT02522338
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Cystatin C, a protease inhibitor produced by most nucleated cells, is freely filtered by the kidneys, and its plasma assay reflects the GFR.

Compare, in HIV patients, the predictive performance of 11 formula to estimate GFR based on assay plasma cystatin C with that of the MDRD formulas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients infected with HIV, and included in the cohort NADIS
Exclusion Criteria
  • Patient with a known allergy
  • Patients treated with metformin
  • Patients with severe hepatic impairment defined as a TP spontaneously below 50%
  • Patients with a history of dysthyroidism
  • Patient with active neoplasia other than skin cancer
  • Degradation recent (not older than 3 months) in renal function defined as the deterioration of GFR over 25%.
  • Estimated GFR less than 15 mL/min/1, 73m2
  • Pregnant or lactating
  • Subjects under the protection of justice

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
iohexol plasma clearanceiohexolpatients had received iohexol for measuring GFR
Primary Outcome Measures
NameTimeMethod
Patient with a predictive performance range -30% to +30%day 0

for each estimator :predictive performance calculated by \[(DFG estimé\* - DFG mesuré par iohexol\*\*)/DFG mesuré par iohexol\]X100

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de SAINT-ETIENNE

🇫🇷

Saint-etienne, France

© Copyright 2025. All Rights Reserved by MedPath